Nutrient-induced inflammation in the intestine

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 4, 2011, Pages 315-321

  Ji, Yong ^a   Sakata, Yasuhisa ^a   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

fatty acids; inflammatory bowel disease; intestinal immune cells; mesenteric lymph; metabolic syndrome; mucosal mast cells

Indexed keywords

CADAVERINE; CHEMOKINE; CHYLOMICRON; COLLAGEN TYPE 4; CYTOKINE; DIAMINE; FAT; G PROTEIN COUPLED RECEPTOR 40; HISTAMINE; I KAPPA B; INTERLEUKIN 13; INTERLEUKIN 8; LEUKOTRIENE; LIPID EMULSION; LIPOSYN II; LONG CHAIN FATTY ACID; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN FATTY ACID; MICROSOMAL AMINOPEPTIDASE; OCCLUDIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2; PROTEINASE; PUTRESCINE; RAT MUCOSAL MAST CELL PROTEASE II; STEM CELL FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; APOPTOSIS; BLOOD VESSEL PERMEABILITY; CD34 SELECTION; CELL ACTIVATION; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CHRONIC INFLAMMATION; DIETARY INTAKE; ENTERITIS; ENTEROENDOCRINE CELL; ENZYME ACTIVITY; EPITHELIUM CELL; EXOCYTOSIS; FOOD INTAKE; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRACT FUNCTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATORY CELL; INSULIN RESISTANCE; INTESTINE ABSORPTION; INTESTINE MUCOSA; LAMINA PROPRIA; LIPID ABSORPTION; LIPID DIET; LYMPHOCYTE; MACROPHAGE; MAST CELL; MESENTERY BLOOD FLOW; METABOLIC SYNDROME X; MUCOSAL MAST CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; DIETARY FATS; DISEASE MODELS, ANIMAL; HISTAMINE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL ABSORPTION; INTESTINES; MAST CELLS; METABOLIC SYNDROME X; PROSTAGLANDIN D2; RATS; SERINE ENDOPEPTIDASES;

ANIMALIA; FISTULA; RATTUS;

EID: 79959212022     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283476e74     Document Type: Review

References (59)

1. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell 2010; 140:859-870.
2. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90:859-904; Review.
3. Chorny A, Puga I, Cerutti A. Innate signaling networks in mucosal IgA class switching. Adv Immunol 2010; 107:31-69.
4. Raybould HE. Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci 2010; 153:41-46.
5. Zeuthen LH, Fink LN, Frokiaer H. Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta. Immunology 2008; 123:197-208.
6. Kvietys PR, Specian RD, Grisham MB, Tso P. Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. Am J Physiol 1991; 261:G384-G391.
7. Miura S, TsuzukiI Y, Hokari R, Issii H. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease. J Gastroenterol Hepatol 1998; 13:1183-1190. (Pubitemid 29029948)
8. Fujiyama Y, Hokari R, Miura S, et al. Butter feeding enhances TNF-alpha production from macrophages and lymphocyte adherence in murine small intestinal microvessels. J Gastroenterol Hepatol 2007; 22:1838-1845. (Pubitemid 47525088)
9. Hara Y, Miura S, Komoto S, et al. Exposure to fatty acids modulates interferon production by intraepithelial lymphocytes. Immunol Lett 2003; 86:139-148. (Pubitemid 36324274)
10. Yoshida H, Miura S, Kishikawa H, et al. Fatty acids enhance GRO/CINC-1 and interleukin-6 production in rat intestinal epithelial cells. J Nutr 2001; 131:2943-2950. (Pubitemid 33063128)
11. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008; 52:885-897; Review.
12. Yamamoto T, Nakahigashi M, Saniabadi AR. Review article: diet and inflammatory bowel disease: epidemiology and treatment. Aliment Pharmacol Ther 2009; 30:99-112.
13. Das UN. Obesity: genes, brain, gut, and environment. Nutrition 2010; 26: 459-473.
14. Greenfield V, Cheung O, Sanyal AJ. Recent advances in nonalcholic fatty liver disease. Curr Opin Gastroenterol 2008; 24:320-327; Review. (Pubitemid 351535891)
15. Ohman MK, Wright AP, Wickenheiser KJ, et al. Visceral adipose tissue and atherosclerosis. Curr Vasc Pharmacol 2009; 7:169-179.
16. Eduardo J. The role of macronutrients in gastrointestinal blood flow. CurrOpin Clin Nutr Metab Care 2005; 8:552-556.
17. Lu WJ, Yang Q, Sun W, et al. Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose. Am J Physiol 2008; 294:G1130-G1138.
18. Yang L, Li X, Ji Y, et al. Effect of ezetimibe on incretin secretion in response to the intestinal absorption of a mixed meal. Am J Physiol Gastrointest Liver Physiol 2010; 299:G1003-G1011.
19. Tso P, Balint JA. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol 1986; 250:G715-G726.
20. Salim SY, Sö derholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17:362-381.
21. Ji Y, Li XM, Yang Q, et al. Intestinal fat absorption is associated with the release of histamine and its degrading enzyme diamine oxidase. Gastroenterol 2009; 136 (Suppl 1):A729.
22. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr 2007; 85:1185-1196. (Pubitemid 46740458)
23. He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 2004; 10:309-318.
24. Jones BL, Kearns GL. Histamine: new thoughts about a familiar mediator. Clin Pharmacol Ther 2011; 89:189-197.
25. Kitanaka J, Kitanaka N, Tsujimura T, et al. Expression of diamine oxidase (histaminase) in guinea-pig tissues. Eur J Pharmacol 2002; 437:179-185. (Pubitemid 34219480)
26. Wolvekamp MC, de Bruin RW. Diamine oxidase: an overview of historical, biochemical and functional aspects. Dig Dis 1994; 12:2-14.
27. Wollin A, Wang XL, Tso P. Nutrients regulate diamine oxidase release from intestinal mucosa. Am J Physiol 1998; 275:R969-R975.
28. Bischoff SC. Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 2009; 31:185-205.
29. Kumar V, Sharma A. Mast cells: emerging sentinel innate immune cells with diverse role in immunity. Mol Immunol 2010; 48:14-25.
30. Stead RH, Colley EC, Wang B, et al. Vagal influences over mast cells. Auton Neurosci 2006; 125:53-61.
31. Sö derholm JD. Mast cells and mastocytosis. Dig Dis 2009; 27 (Suppl 1): 129-136.
32. Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol 2007; 13:3027-3030. (Pubitemid 47045457)
33. Chang SY, Kweon MN. Langerin-expressing dendritic cells in gut-associated lymphoid tissues. Immunol Rev 2010; 234:233-246.
34. van Wijk F, Cheroutre H. Intestinal T cells: facing the mucosal immune dilemma with synergy and diversity. Semin Immunol 2009; 21:130-138.
35. Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009; 31:401-411.
36. Platt AM, Mowat AM. Mucosal macrophages and the regulation of immune responses in the intestine. Immunol Lett 2008; 119:22-31.
37. Tsuzuki Y, Miyazaki J, Matsuzaki K, et al. Differential modulation in the functions of intestinal dendritic cells by long-and medium-chain fatty acids. J Gastroenterol 2006; 41:209-216.
38. Van Nassauw L, Adriaensen D, Timmermans JP. The bidirectional communication between neurons and mast cells within the gastrointestinal tract. Auton Neurosci 2007; 133:91-103. (Pubitemid 46483256)
39. Santos J, Alonso C, Guilarte M, et al. Targeting mast cells in the treatment of functional gastrointestinal disorders. Curr Opin Pharmacol 2006; 6:541-546. (Pubitemid 44660942)
40. Geraedts MC, Troost FJ, Saris WH. Gastrointestinal targets to modulate satiety and food intake. Obes Rev 2010. doi: 10.1111/j.1467-789X. 2010.00788.x.
41. Sternini C, Anselmi L, Rozengurt E. Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes 2008; 15:73-78.
42. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol 2009; 9:778-788.
43. Marion-Letellier R, Dé chelotte P, Iacucci M, Ghosh S. Dietary modulation of peroxisome proliferator-activated receptor gamma. Gut 2009; 58:586-593.
44. Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142:687-698.
45. Keita AV, Sö derholm JD. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 2010; 22:718-733.
46. Scudamore CL, Jepson MA, Hirst BH, Miller HR. The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occluding. Eur J Cell Biol 1998; 75:321-330. (Pubitemid 28206294)
47. Patrick MK, Dunn IJ, Buret A, et al. Mast cell protease release and mucosal ultrastructure during intestinal anaphylaxis in the rat. Gastroenterology 1988; 94:1-9. (Pubitemid 18029753)
48. Bassaganya-Riera J, Hontecillas R. Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2010; 13:569-573.
49. Rakoff-Nahoum S, Bousvaros A. Innate and adaptive immune connections in inflammatory bowel diseases. Curr Opin Gastroenterol 2010; 26:572-577.
50. Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol 2008; 14:348-353. (Pubitemid 351320844)
51. de La Serre CB, Ellis CL, Lee J, et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation.Am J Physiol Gastrointest Liver Physiol 2010; 299:G440-G448.
52. Suzuki T, Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond) 2010; 7:19.
53. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867. (Pubitemid 46024993)
54. Pfü tzner A, Weber MM, Forst T. A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type .2. diabetes mellitus. Clin Lab 2008; 54:485-490; Review.
55. Sell H, Eckel J. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care 2010; 13:366-370.
56. Deng Y, Scherer PE. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 2010; 1212:E1-E19.
57. Ding S, Chi MM, Scull BP, et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010; 5:e12191.
58. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007; 86:1286-1292. (Pubitemid 350126229)
59. Liu J, Divoux A, Sun J, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009; 15:940-945.